Related references
Note: Only part of the references are listed.Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up
I. Kyvernitakis et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis
Namki Hong et al.
CLINICAL ENDOCRINOLOGY (2018)
Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density
K. E. Naylor et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Pregnancy-associated osteoporosis: a case-control study
P. Hadji et al.
OSTEOPOROSIS INTERNATIONAL (2017)
MATERNAL MINERAL AND BONE METABOLISM DURING PREGNANCY, LACTATION, AND POST-WEANING RECOVERY
Christopher S. Kovacs
PHYSIOLOGICAL REVIEWS (2016)
Presentation and management of osteoporosis presenting in association with pregnancy or lactation
C. S. Kovacs et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Postpartum osteoporosis and vertebral fractures in two patients treated with enoxaparin during pregnancy
D. Ozdemir et al.
OSTEOPOROSIS INTERNATIONAL (2015)
ENDOCRINOLOGY IN PREGNANCY Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture
Lucia Sanz-Salvador et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Pregnancy-Associated Osteoporosis With a Heterozygous Deactivating LDL Receptor-Related Protein 5 ( LRP5) Mutation and a Homozygous Methylenetetrahydrofolate Reductase ( MTHFR) Polymorphism
Fiona J. Cook et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Osteoporotic Vertebral Fractures During Pregnancy: Be Aware of a Potential Underlying Genetic Cause
Natalia Campos-Obando et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Osteoporosis presenting in pregnancy, puerperium, and lactation
Christopher S. Kovacs
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2014)
Case Report: Teriparatide treatment in a case of severe pregnancy -and lactation- associated osteoporosis
Kalliopi Lampropoulou-Adamidou et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2012)
Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures
Eun Yeong Choe et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2012)
Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study
U. K. Moller et al.
OSTEOPOROSIS INTERNATIONAL (2012)
The use of bisphosphonates in women prior to or during pregnancy and lactation
Stathopoulos P. Ioannis et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2011)
Treatment with teriparatide in a patient with pregnancy-associated osteoporosis
Lars Hellmeyer et al.
GYNECOLOGICAL ENDOCRINOLOGY (2010)
Pregnancy outcome following in utero exposure to bisphosphonates
Shirley Levy et al.
BONE (2009)
The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment
Asher Ornoy et al.
REPRODUCTIVE TOXICOLOGY (2006)
Bisphosphonates in pregnancy and lactation-associated osteoporosis
SM O'Sullivan et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra®) on human osteoblasts in vitro
AE Handschin et al.
BRITISH JOURNAL OF SURGERY (2005)
Recovery of pregnancy mediated bone loss during lactation
D Pearson et al.
BONE (2004)
Share Paper
